China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a research note published on Tuesday. The brokerage issued a hold rating on the stock.

China Pharma Stock Performance

China Pharma stock opened at $1.51 on Tuesday. China Pharma has a twelve month low of $1.20 and a twelve month high of $4.10. The business has a fifty day moving average of $21.52 and a two-hundred day moving average of $21.57. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.